ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,449, issued on Oct. 14, was assigned to Jazz Pharmaceuticals Ireland Ltd. (Dublin).
"Alcohol-resistant drug formulations" was invented by Edwin Walsh (Dublin) and Clark Patrick Allphin (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to modified release oral formulations of therapeutic agents, including gamma hydroxybutyrate (GHB), paracetamol, codeine or oxycodone, which are resistant to alcohol induced dose dumping. Provided are formulations that have improved resistance to rapid release of the active ingredient in the presence of increasing amounts of alcohol. Also provided are formulations that can reduce or prevent ...